Hormone concentration measurement in intracranial dural arteriovenous fistulae.
DAVF
cavernous sinus
endovascular
estradiol
intracranial dural arteriovenous fistulae
sex hormone
transverse sinus
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
15 Feb 2024
15 Feb 2024
Historique:
received:
03
12
2023
revised:
08
02
2024
accepted:
09
02
2024
medline:
18
2
2024
pubmed:
18
2
2024
entrez:
17
2
2024
Statut:
aheadofprint
Résumé
Intracranial dural arteriovenous fistulae (DAVF) represent a subset of cerebral vascular malformations associated with significant morbidity and mortality. In Japan, DAVF exhibits sex-based differences in anatomical distribution, with female predominance in the cavernous sinus (CS) and male predominance in the transverse sinus (TS). Nevertheless, the pathophysiology of DAVF is not fully understood, and hormonal influences are hypothesized to play a role in its development. This study aimed to investigate changes in the concentrations of sex steroid hormones between intracranial and peripheral sampling sites in CS- and TS-DAVF patients. We recruited 19 patients with CS-DAVF (n=12) and TS-DAVF (n=7) in this study. Blood hormone measurements were obtained from peripheral and jugular bulb (JB) samples during endovascular intervention. Hormone concentrations were analyzed using enzyme-linked immunosorbent assay kits, and statistical analyses were performed. Our study revealed a higher prevalence of CS-DAVF in females and TS-DAVF in males, which is consistent with previous studies. Estradiol concentration was significantly lower in the JB compared with in the periphery in both CS- and TS-DAVF patients. This decrease in estradiol was observed irrespective of the patient's sex and independent of FSH levels. These findings indicate a local decrease in estradiol levels within the intracranial vasculature of DAVF patients. This suggests a potential multifactorial role of estradiol in the pathomechanism of DAVFs, warranting further investigation to understand its influence on DAVF formation and potential targeted therapies, thereby enhancing patient outcomes.
Identifiants
pubmed: 38367858
pii: S1878-8750(24)00250-X
doi: 10.1016/j.wneu.2024.02.052
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.